These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 16259567

  • 1. Effective growth arrest of human colon cancer in mice, using rat sodium iodide symporter and radioiodine therapy.
    Mitrofanova E, Unfer R, Vahanian N, Kane S, Carvour M, Link C.
    Hum Gene Ther; 2005 Nov; 16(11):1333-7. PubMed ID: 16259567
    [Abstract] [Full Text] [Related]

  • 2. Rat sodium iodide symporter for radioiodide therapy of cancer.
    Mitrofanova E, Unfer R, Vahanian N, Daniels W, Roberson E, Seregina T, Seth P, Link C.
    Clin Cancer Res; 2004 Oct 15; 10(20):6969-76. PubMed ID: 15501976
    [Abstract] [Full Text] [Related]

  • 3. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 2000 Nov 15; 60(22):6526-30. PubMed ID: 11103823
    [Abstract] [Full Text] [Related]

  • 4. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E, Unfer R, Vahanian N, Link C.
    Gene Ther; 2006 Jul 15; 13(13):1052-6. PubMed ID: 16525480
    [Abstract] [Full Text] [Related]

  • 5. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.
    Mandell RB, Mandell LZ, Link CJ.
    Cancer Res; 1999 Feb 01; 59(3):661-8. PubMed ID: 9973215
    [Abstract] [Full Text] [Related]

  • 6. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ.
    Cancer Gene Ther; 2003 Jan 01; 10(1):14-22. PubMed ID: 12489024
    [Abstract] [Full Text] [Related]

  • 7. Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats.
    Faivre J, Clerc J, Gérolami R, Hervé J, Longuet M, Liu B, Roux J, Moal F, Perricaudet M, Bréchot C.
    Cancer Res; 2004 Nov 01; 64(21):8045-51. PubMed ID: 15520214
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
    Mitrofanova E, Hagan C, Qi J, Seregina T, Link C.
    Anticancer Res; 2003 Nov 01; 23(3B):2397-404. PubMed ID: 12894520
    [Abstract] [Full Text] [Related]

  • 11. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
    Shi S, Zhang M, Guo R, Miao Y, Hu J, Xi Y, Li B.
    PLoS One; 2015 Nov 01; 10(1):e0116531. PubMed ID: 25621996
    [Abstract] [Full Text] [Related]

  • 12. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2005 Feb 01; 12(3):272-80. PubMed ID: 15510175
    [Abstract] [Full Text] [Related]

  • 13. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C.
    J Nucl Med; 2015 Apr 01; 56(4):600-6. PubMed ID: 25745085
    [Abstract] [Full Text] [Related]

  • 14. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC.
    Clin Cancer Res; 2005 Feb 15; 11(4):1483-9. PubMed ID: 15746050
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC.
    Cancer Res; 2003 Nov 15; 63(22):7840-4. PubMed ID: 14633711
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
    Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CY, Göke B, Morris JC.
    Endocrinology; 2003 Aug 15; 144(8):3423-32. PubMed ID: 12865321
    [Abstract] [Full Text] [Related]

  • 18. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice.
    Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC.
    Gene Ther; 2006 Jan 15; 13(1):60-6. PubMed ID: 16121204
    [Abstract] [Full Text] [Related]

  • 19. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
    Hsieh YJ, Ke CC, Liu RS, Wang FH, Tang KT, Chi CW, Chen FD, Lee CH.
    Anticancer Res; 2007 Jan 15; 27(4B):2515-22. PubMed ID: 17695547
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.